30.92Average Price Target
The highest estimate is 39.46.
From 4 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow 7BA.STU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Show more...
FAQ
What is BioAmber stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange BioAmber stocks are traded under the ticker 7BA.STU.
When is the next BioAmber earnings date?▼
BioAmber is going to release the next earnings report on November 05, 2026.
What were BioAmber earnings last quarter?▼
7BA.STU earnings for the last quarter are -0.5 EUR per share, whereas the estimation was -0.53 EUR resulting in a +4.5% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is BioAmber revenue for the last year?▼
BioAmber revenue for the last year amounts to 7.76M EUR.
What is BioAmber net income for the last year?▼
7BA.STU net income for the last year is -69.54M EUR.
How many employees does BioAmber have?▼
As of September 05, 2026, the company has 62 employees.
In which sector is BioAmber located?▼
BioAmber operates in the Health & Wellness sector.
When did BioAmber complete a stock split?▼
BioAmber has not had any recent stock splits.
Where is BioAmber headquartered?▼
BioAmber is headquartered in EMERYVILLE, United States.